Navigation Links
Elsevier introduces Cardiac Electrophysiology Clinics
Date:4/27/2010

Philadelphia, 27 April 2010 - Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces a new addition to the Clinics of North America series Cardiac Electrophysiology Clinics.

Under the expert guidance of Consulting Editors Dr. Ranjan Thakur and Dr. Andrea Natale, each issue is devoted to a single topic that covers the most significant concerns in this field. According to Dr. Thakur, the goal of Cardiac Electrophysiology Clinics is "to provide comprehensive reviews of contemporary issues of interest to clinicians. Electrophysiologists as well as other cardiologists and physicians caring for patients with arrhythmias will find these issues helpful in clinical decision making."

Dr. Thakur is Professor of Medicine and Program Director of the Cardiac Electrophysiology Fellowship at Michigan State University and Director of the Arrhythmia Service at the Thoracic and Cardiovascular Institute, Sparrow Health System, in Lansing, Michigan. Dr. Natale is Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin Texas.

The initial issues of this quarterly publication feature the following topics:

  • Sudden Cardiac Death: Despite emergency medical response systems, long-term survival from out-of-hospital cardiac arrest remains poor in most US cities. This issue covers the full spectrum of issues related to sudden cardiac death, including the epidemiology of sudden cardiac death, advances in CPR, the implantable cardiac defibrillator (ICD), and ventricular tachycardia ablation.

  • Epicardial Interventions in Electrophysiology: Epicardial ablation is a relatively new technique that is less invasive than traditional surgical ablation. It shows promise in certain patient populations. This issue of Cardiac Electrophysiology Clinics is one of the first collections of articles on this cutting edge technique.

  • Advances in Arrhythmia Analyses: A Case-Based Approach: This issue is a valuable tool to help electrophysiologists interpret complex ECGs so they can better understand arrhythmia mechanisms. Organized by cases, this issue illustrates many of the classic electrocardiographic findings and phenomena that every electrophysiologist should know.

  • Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Arrhythmogenic right ventricular dysplasia is an inherited heart muscle disorder that may cause abnormal electrical heart rhythms and weakening of the pumping action of the heart, resulting in sudden death. The electrocardiograph (EKG) is used to diagnose the disease, so it is important for cardiac electrophysiologists to be familiar with the disease and to be able to recognize it on the EKG.

  • Advances in Antiarrhythmic Drug Therapy: Cardiac electrophysiologists have many options for treating arrhythmias, including catheter ablation and implantable cardiac defibrillators. Antiarrhythmic agents, which are pharmaceutical agents used to suppress fast rhythms of the heart (cardiac arrhythmias), represent another treatment option. This issue summarizes the most current thinking on the role of pharmaceuticals in relation to other types of treatment, helping electrophysiologists to determine the best method for managing their patients.


'/>"/>

Contact: Barbara Cohen-Kligerman
b.cohen-kligerman@elsevier.com
215-239-6109
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches Carpentiers reconstructive valve surgery book
2. Elseviers Journal of Evidence-Based Dental Practice celebrates 10th year with special issue
3. Elseviers new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
4. Elsevier introduces innovative new pharmacology text
5. Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog
6. Clone Systems, Inc. Introduces On-Demand Penetration Testing Service
7. ORCS Web, Inc Introduces Windows Cloud Server
8. HeartCoaches Introduces Brain-Based Strategies for a Healthy Heart
9. Cosmetic Peptides that Significantly Reduce Length and Depth of Wrinkles: Janet Sartin Introduces Advanced Anti-Wrinkle Peptide Serum for All Skin Types
10. Dxtra Introduces New Solid Stainless Steel Mouse Pad
11. OPTP Introduces the Pilates TRIADBALL™ Manual
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: